PD1 antibody [NAT105]

Catalog number: GTX20256
Brand: GeneTex
Packing: 500 ul
Price: € 438.00
Expected delivery time: 10 days
GTX20256 IHC-P Image
IHC-P analysis of human tonsil tiss...

Product specifications for - PD1 antibody [NAT105]

Product group: Antibodies
Category: Primary Antibodies
Application: FACS, ICC/IF, ImmunoHistoChemistry, IHC-Fr, IHC-P, ImmunoPrecipitation, Western Blot
Species: Human, Mouse
Host: Mouse
Target: PDCD1
Target description: programmed cell death 1
Clonality: Monoclonal
Conjugation: Unconjugated
Isotype: IgG1
Datasheet: Datasheet
  Research Use Only
UNSPSC: 12352203
Storage instructions: Keep as concentrated solution. For short-term storage, store at 4°C (up to 10 days). For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
Scientific information: 
Clone ID: NAT105
Gene ID: 5133
Swiss prot ID: Q15116
Additional information: 
Synonyms: GTX20256; CD279; PD-1; PD1; SLEB2; hPD-1; hPD-l; hSLE1; programmed cell death protein 1; programmed cell death 1 protein; protein PD-1; systemic lupus erythematosus susceptibility 2
Kammerer-Jacquet SF, "Independent association of PD-L1 expression with noninactivated VHL clear cell renal cell carcinoma-A finding with therapeutic potential". Int J Cancer 140 (1), page 142-148. Read more
Bastman JJ, "Tumor-Infiltrating T Cells and the PD-1 Checkpoint Pathway in Advanced Differentiated and Anaplastic Thyroid Cancer". J Clin Endocrinol Metab 101 (7), page 2863-73. Read more
Li CW, "Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity". Nat Commun 7, page 12632. Read more
Dronca RS, "T cell Bim levels reflect responses to anti-PD-1 cancer therapy". JCI Insight 1 (6). Read more
Paulsen EE, "Assessing PDL-1 and PD-1 in Non-Small Cell Lung Cancer: A Novel Immunoscore Approach". Clin Lung Cancer. Read more
Kaewkangsadan V, "Crucial Contributions by T Lymphocytes (Effector, Regulatory, and Checkpoint Inhibitor) and Cytokines (TH1, TH2, and TH17) to a Pathological Complete Response Induced by Neoadjuvant Chemotherapy in Women with Breast Cancer". J Immunol Res 2016, page 4757405. Read more
Mishra V, "Differential induction of PD-1/PD-L1 in Neuroimmune cells by drug of abuse". Int J Physiol Pathophysiol Pharmacol 7 (2), page 87-97. Read more
Joseph RW, "Lichenoid dermatitis in three patients with metastatic melanoma treated with anti-PD-1 therapy". Cancer Immunol Res 3 (1), page 18-22. Read more
Smeltzer JP, "Pattern of CD14+ follicular dendritic cells and PD1+ T cells independently predicts time to transformation in follicular lymphoma". Clin Cancer Res 20 (11), page 2862-72. Read more
Cogbill CH, "Utility of CD279/PD-1 immunohistochemistry in the evaluation of benign and neoplastic T-cell-rich bone marrow infiltrates". Am J Clin Pathol 142 (1), page 88-98. Read more